作者: Franco Muggia , Leslie I. Gold , John Curtin
DOI: 10.1007/978-1-60327-044-1_15
关键词:
摘要: The biology of endometrial cancer is providing new therapeutic targets. In this chapter we review (a) how the integration chemotherapy has been taking place; (b) targeted therapies and immunotherapies being tested in treatment these malignancies; (c) targets worthy consideration based on uterine cancers; (d) other consequences such as advances reduction morbidity toxicity associated with past practices; (e) special entities issues to be considered.